
Juul Targeted Schools, Camps and Youth Programs, House Panel Claims
Lawmakers grilled company officials about financing programs aimed at appealing to young people that familiarized them with Juul’s products.
By
Advertisement
Supported by

Lawmakers grilled company officials about financing programs aimed at appealing to young people that familiarized them with Juul’s products.
By

Hundreds of thousands of Americans have coronary bypass surgery each year, and few die. Here’s what experts say happened to a national hero.
By

The state is providing up to $300,000 in debt relief for doctors who agree to accept Medicaid. The grant has lifted “an emotional burden,” one recipient said, adding, “I can focus on my patients.”
By Emily S. Rueb and

Under pressure from the Food and Drug Administration, Allergan will stop selling textured implants. Thirty-three deaths have been tied to the devices.
By

Long hours, disrupted sleep and constant stress can take a biological toll on newly minted doctors. Down to the level of their genes.
By

Computer scientists have developed an algorithm that can pick out almost any American in databases supposedly stripped of personal information.
By

In preliminary tests, a matchstick-size rod containing a new drug offered promise as a shield against the virus. But a large clinical trial must still be done.
By

“Something happened to the brain” of diplomats who reported odd ailments, a brain-imaging study suggests. But the cause is still unclear.
By

Is there any effective way to manage food cravings related to premenstrual syndrome?
By
Advertisement

Overuse of antibiotics in livestock has given rise to drug-resistant germs. Drugmakers say they want to be part of the solution. But a recent campaign urged farmers to administer the drugs to healthy animals daily.
By Danny Hakim and

The state health department calls on hospitals to do more to fight Candida auris, a mystery germ spreading the globe.
By

In its decision to approve two drugs for orange and grapefruit trees, the E.P.A. largely ignored objections from the C.D.C. and the F.D.A., which fear that expanding their use in cash crops could fuel antibiotic resistance in humans.
By Andrew Jacobs and

A new report says the overuse of antimicrobial drugs in humans, animals and plants is fueling resistant pathogens that could kill 10 million people annually by 2050.
By

The mysterious infection has appeared at hospitals around the world, but few institutions or families have discussed their experience.
By
Advertisement
Advertisement